Janssen Inc. v. Apotex Inc., 2019 FC 1355
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Citation | 2019 FC 1355 |
| Date | 29 October 2019 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
21 practice notes
-
Janssen Inc. v. Pharmascience Inc., 2022 FC 62
...Corporation v. Kennedy Trust for Rheumatology, 2018 FC 259 , rev’d in part 2020 FCA 30 [Hospira]; Janssen Inc. v. Apotex Inc., 2019 FC 1355, aff’d 2021 FCA 45 ]. [101] In the present case, |||||||||||||||||||||||||||||||||||||||||| alone is not the patented article of the asserted claim......
-
Allergan Inc. v. Apotex Inc., 2022 FC 260
...I note that the jurisprudence is mixed on the treatment of blinded evidence. I favour the approach noted in Janssen Inc v Apotex Inc, 2019 FC 1355 at paras 58-59 [Janssen 2019], that blinded opinions are not necessarily given greater weight just because they are blinded. As noted by the Cou......
-
SIDE WIND: THE RIGHT-HOLDER'S QUEST FOR INTELLECTUAL PROPERTY ENFORCEMENT.
...FCA 228 at para 162 (on the legal test for inducing others to infringe). (166) 2021 FCA 45 [Apotex FCA], aff'g Janssen Inc v Apotex Inc, 2019 FC 1355 (167) Apotex FCA, supra note 166 at para 57. See also Apotex FC, supra note 166 at para 232. (168) Apotex FCA, supra note 166 at para 18. (16......
-
Teva Canada Innovation v. Pharmascience Inc., 2020 FC 1158
...which the Court can draw a reasonable inference (Corlac Inc v Weatherford Canada Inc, 2011 FCA 228 at para 162; Janssen Inc v Apotex Inc, 2019 FC 1355 at para 235). [926] Pharmascience’s regulatory expert, Ms. Picard, explained that a product monograph describes the properties, claims, indi......
Request a trial to view additional results
10 cases
-
Janssen Inc. v. Pharmascience Inc., 2022 FC 62
...Corporation v. Kennedy Trust for Rheumatology, 2018 FC 259 , rev’d in part 2020 FCA 30 [Hospira]; Janssen Inc. v. Apotex Inc., 2019 FC 1355, aff’d 2021 FCA 45 ]. [101] In the present case, |||||||||||||||||||||||||||||||||||||||||| alone is not the patented article of the asserted claim......
-
Allergan Inc. v. Apotex Inc., 2022 FC 260
...I note that the jurisprudence is mixed on the treatment of blinded evidence. I favour the approach noted in Janssen Inc v Apotex Inc, 2019 FC 1355 at paras 58-59 [Janssen 2019], that blinded opinions are not necessarily given greater weight just because they are blinded. As noted by the Cou......
-
Teva Canada Innovation v. Pharmascience Inc., 2020 FC 1158
...which the Court can draw a reasonable inference (Corlac Inc v Weatherford Canada Inc, 2011 FCA 228 at para 162; Janssen Inc v Apotex Inc, 2019 FC 1355 at para 235). [926] Pharmascience’s regulatory expert, Ms. Picard, explained that a product monograph describes the properties, claims, indi......
-
Apotex Inc. v. Janssen Inc., 2021 FCA 45
...THE MINISTER OF HEALTH Respondents REASONS FOR JUDGMENT LOCKE J.A. I. Background [1] This is an appeal of a decision of the Federal Court (2019 FC 1355, per Phelan J.), which granted an application by the respondents Janssen Inc., Janssen Oncology Inc. and BTG International Ltd. (collective......
Request a trial to view additional results
10 firm's commentaries
-
2019 Litigation Year In Review
...and https://www.ippractice.ca/litigation-statistics/intellectual-property-proceedings-in-federal-court-for-2018/ > 52 See for example 2019 FC 1355 53 2019 FC 191 54 Ibid at para 21 55 2019 FC 1039 The content of this article is intended to provide a general guide to the subject matter. Spec......
-
Canadian Patent Law: 2019 Year In Review
...arginine salt combination. Other notable patent cases Last PMNOC Application Granted Under the Old Scheme In Janssen Inc v Apotex Inc, 2019 FC 1355, Justice Phelan granted Janssen's application for an order prohibiting the issuance of a Notice of Compliance to Apotex for its generic version......
-
Federal Court Of Appeal Rejects Apotex's Appeal For Inclusion Onto Patented Medicines List
...Inc. v. Janssen Inc., 2021 FCA 45, the Federal Court of Appeal recently dismissed an appeal of the Federal Court decision 2019 FC 1355 by Apotex. The Federal Court granted an application by Janssen to prohibit the Minister of Health from granting a Notice of Compliance to Apotex for its pro......
-
Federal Court Of Appeal Upholds One Of The Last Prohibition Orders Under The Old PM(NOC) Regulations
...Federal Court held that the 422 Patent was valid, infringed by Apotex Inc. (Apotex), and eligible to be listed on the Patent Register ( 2019 FC 1355, the First Following the September 2017 amendments to the PM(NOC) Regulations, a second Federal Court proceeding was commenced by way of actio......
Request a trial to view additional results
1 books & journal articles
-
SIDE WIND: THE RIGHT-HOLDER'S QUEST FOR INTELLECTUAL PROPERTY ENFORCEMENT.
...FCA 228 at para 162 (on the legal test for inducing others to infringe). (166) 2021 FCA 45 [Apotex FCA], aff'g Janssen Inc v Apotex Inc, 2019 FC 1355 (167) Apotex FCA, supra note 166 at para 57. See also Apotex FC, supra note 166 at para 232. (168) Apotex FCA, supra note 166 at para 18. (16......